Indian equity markets experienced a choppy trading session on Tuesday, closing on a muted note amid geopolitical developments and cautious sentiment following the US Federal Reserve's commentary. Despite the broader market's cautious stance, several individual stocks have garnered attention from brokerage firms, with specific buy recommendations issued for Wednesday's trading session.
Analysts from Canara Bank Securities and SMIFS have highlighted Shriram Finance, Glenmark Pharmaceuticals, and PCBL Chemical as stocks with potential upside, backed by technical indicators and market momentum. Here's a detailed look at their recommendations:
Shriram Finance: Bullish Breakout Signaled
Recommendation: Buy
Canara Bank Securities has issued a 'Buy' recommendation for Shriram Finance, citing a long-term bullish trendline breakout. The stock is currently trading above all major moving averages, indicating robust momentum and a strengthening trend structure. It has successfully sustained above the crucial Rs 1,055 breakout zone.
- Current Market Price (at recommendation): Rs 1,037
- Target Price: Rs 1,104 - Rs 1,146
- Stop Loss: Rs 986
The Relative Strength Index (RSI) is positioned near 67, signaling strong momentum, though slightly overheated in the short term. Volume expansion during the breakout phase further supports the credibility of this upward move. If the stock maintains above Rs 1,104, momentum is expected to continue towards Rs 1,146 and potentially higher levels, with immediate support shifting to Rs 1,026.
Glenmark Pharmaceuticals: Accumulate on Dips
Recommendation: Buy (Accumulate on dips)
SMIFS recommends accumulating Glenmark Pharmaceuticals, which has been in a prolonged consolidation phase following an earlier rally. The stock is trading near a key support zone of Rs 2,000–2,100 and has repeatedly defended this range, suggesting sustained buying interest.
- Accumulation Zone: Rs 2,100 - Rs 2,200
- Target Price (6-month): Rs 2,600
- Stop Loss (closing basis): Below Rs 2,000
Technically, Glenmark continues to trade above its 100-day and 200-day moving averages. The flattening short-term Exponential Moving Average (EMA) cluster points to a volatility compression that could precede a fresh directional move. The overall strength in the pharmaceutical sector also enhances the probability of Glenmark participating in the next leg of a rally. Immediate support is at Rs 2,100, followed by Rs 2,050 and Rs 2,000, while resistance levels are identified at Rs 2,300, Rs 2,450, and Rs 2,600.
PCBL Chemical: Strong Bullish Trendline Breakout
Recommendation: Buy
Canara Bank Securities also recommends buying PCBL Chemical, noting a long-term bullish trendline breakout on its charts. The stock has moved above all major moving averages, indicating improving momentum and a strengthened trend structure. It is currently sustaining above the key Rs 327 breakout zone.
- Current Market Price (at recommendation): Rs 321
- Target Price: Rs 348 - Rs 372
- Stop Loss: Rs 304
The RSI for PCBL Chemical is around 66, reflecting strong momentum, though it appears slightly overheated in the short term. Volume expansion during the breakout phase adds credibility to this upward movement. If the stock sustains above Rs 348, momentum is likely to be maintained towards Rs 372 and potentially higher levels, with immediate support shifting to Rs 309.
Disclaimer: This article provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.